These findings highlight the critical role of HPA, HPT and HPO axis dysregulation in both AD pathology and behavioral and psychological symptoms of dementia (BPSD), suggesting that hormonal modulation may serve as a potential therapeutic strategy for both neuropsychiatric symptoms and disease progression in AD. The gene discussed is GFER; the disease is Alzheimer disease.